BidaskClub lowered shares of Kindred Healthcare, Inc. (NYSE:KND) from a sell rating to a strong sell rating in a report issued on Tuesday morning.

KND has been the subject of several other reports. Barclays PLC reaffirmed a buy rating and set a $13.00 price objective (up from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th. Deutsche Bank AG decreased their price objective on shares of Kindred Healthcare from $13.00 to $10.00 and set a buy rating for the company in a report on Monday, August 7th. Royal Bank Of Canada reiterated a hold rating and set a $10.00 target price on shares of Kindred Healthcare in a research note on Friday, May 5th. Zacks Investment Research cut shares of Kindred Healthcare from a hold rating to a sell rating in a research note on Thursday, July 6th. Finally, Mizuho reiterated a neutral rating and set a $9.00 target price on shares of Kindred Healthcare in a research note on Monday, July 3rd. Four analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of $9.94.

Kindred Healthcare (NYSE:KND) traded up 1.38% during mid-day trading on Tuesday, hitting $7.35. 1,229,855 shares of the stock traded hands. The company’s market cap is $639.59 million. Kindred Healthcare has a 12 month low of $5.65 and a 12 month high of $11.90. The stock’s 50 day moving average is $10.24 and its 200-day moving average is $9.20.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.16 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.59 billion. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. Kindred Healthcare’s quarterly revenue was down 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.38 EPS. On average, equities research analysts anticipate that Kindred Healthcare will post $0.57 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.thecerbatgem.com/2017/08/12/kindred-healthcare-inc-nyseknd-downgraded-to-strong-sell-at-bidaskclub.html.

A number of institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its position in Kindred Healthcare by 0.3% in the second quarter. BlackRock Inc. now owns 10,808,864 shares of the health services provider’s stock valued at $125,923,000 after buying an additional 29,673 shares during the last quarter. Vanguard Group Inc. boosted its position in Kindred Healthcare by 8.6% in the second quarter. Vanguard Group Inc. now owns 8,031,919 shares of the health services provider’s stock valued at $93,572,000 after buying an additional 635,000 shares during the last quarter. Wellington Management Group LLP boosted its position in Kindred Healthcare by 40.9% in the first quarter. Wellington Management Group LLP now owns 7,945,247 shares of the health services provider’s stock valued at $66,342,000 after buying an additional 2,307,814 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Kindred Healthcare by 5.6% in the second quarter. Dimensional Fund Advisors LP now owns 6,004,440 shares of the health services provider’s stock valued at $69,952,000 after buying an additional 315,752 shares during the last quarter. Finally, Bank of America Corp DE boosted its position in Kindred Healthcare by 0.6% in the first quarter. Bank of America Corp DE now owns 2,425,910 shares of the health services provider’s stock valued at $20,257,000 after buying an additional 13,774 shares during the last quarter. Hedge funds and other institutional investors own 88.88% of the company’s stock.

About Kindred Healthcare

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Stock Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related stocks with our FREE daily email newsletter.